Testing for Guanidinoacetate Methyltransferase (GAMT) deficiency
The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that as of January 2025, all newborns are being screened for Guanidinoacetate methyltransferase (GAMT) deficiency through the newborn screening process. If you have any questions, please contact …
Testing for Mucopolysaccharidosis Type II (MPS II)
The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that beginning July 1, 2024, all newborns screened will be tested for Mucopolysaccharidosis Type II (MPS II). If you have any questions, please contact the Florida NBS …
Florida Guidelines for Newborn Hearing Screening Revised
The Florida Newborn Hearing Screening/Early Hearing Detection and Intervention Program is pleased to announce that beginning December 9, 2021, the Florida Guidelines for Newborn Hearing Screening have been revised. For more information or questions about hearing screenings or the revised …
Testing for Spinal Muscular Atrophy (SMA)
The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that beginning April 27, 2020, all newborns screened will be tested for a new condition, Spinal Muscular Atrophy (SMA). If you have any questions, please contact the …
Testing for Pompe Disease (Pompe) and Mucopolysaccharidosis Type I (MPS I)
The Florida Department of Health, Newborn Screening Program, is pleased to announce that beginning February 3, 2020, all newborns screened will be tested for Pompe Disease (Pompe) and Mucopolysaccharidosis Type I (MPS I). If you have any questions, please contact …